Literature DB >> 30848518

Overexpression of Axl reverses endothelial cells dysfunction in high glucose and hypoxia.

Zuo Pei-Yuan1, Liu Yu-Wei2, Zha Xiang-Nan3, Tong Song4, Zhang Rong5, He Xiao-Xiao6, Shan Sheng-Shuai7, Wang Kun7, Liu Cheng-Yun7.   

Abstract

The receptor tyrosine kinase Axl is involved in diabetic vascular disease. This study aims to investigate the effect of high glucose on endothelial cells injury and Axl expression in hypoxia condition in vitro, and we present details of the mechanism associated with overexpression of Axl rescue the high glucose injury. Our results showed that high glucose impaired both human umbilical vein endothelial cells (HUVECs) and EAhy926 cells angiogenesis in hypoxia condition. In addition, high glucose inhibits Axl and hypoxia-inducible factor 1-α (HIF-1α) protein expression in hypoxia condition. Axl overexpression significantly reversed endothelial cells dysfunction in high glucose/hypoxia. Furthermore, Axl overexpression in EAhy926 cells increases HIF-1α protein synthesis through PI3K/Akt/mTOR/p70 S6K signal pathway but not Mek/Erk in high glucose/hypoxia condition. This study demonstrates that high glucose can alter Axl signaling and HIF-1α in hypoxia condition. Overexpression of Axl may rescue endothelial cells dysfunction and HIF-1α expression through its downstream signals in high glucose/hypoxia.
© 2019 Wiley Periodicals, Inc.

Entities:  

Keywords:  Axl; angiogenesis; endothelial cell; high glucose; hypoxia

Year:  2019        PMID: 30848518     DOI: 10.1002/jcb.28462

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  1 in total

1.  Downregulation of lncRNA MIR181A2HG by high glucose impairs vascular endothelial cell proliferation and migration through the dysregulation of the miRNAs/AKT2 axis.

Authors:  Shaohua Wang; Bin Zheng; Hongye Zhao; Yongjun Li; Xinhua Zhang; Jinkun Wen
Journal:  Int J Mol Med       Date:  2021-02-04       Impact factor: 4.101

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.